Close Menu
  • Home
  • International
  • News
  • Lifestyle
  • Law
  • Business
  • Education
  • Vaping

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Review: Lodestone LC Lite – Innokin

March 4, 2026

Unveiling the Surprising Health Benefits of Nicotine

March 4, 2026

Why Accessories Matter to Cannabis Companies Playing the Long Game – Cannabis & Tech Today

March 4, 2026
Facebook X (Twitter) Instagram
Thursday, March 5
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Insights
  • Home
  • International

    Medical Cannabis Patient Cleared of Wrongful Driving Conviction

    February 19, 2026

    US State Considers Medical Cannabis in Female Orgasm Disorder

    February 5, 2026

    First Placebo-Controlled Trial Finds Cannabis Effective For Migraine

    January 28, 2026

    Using Data for Advanced Access

    January 24, 2026

    The UK’s Cannabis Media Storm

    January 22, 2026
  • News

    Ananda Pharma to Begin Dosing in NHS CBD Endometriosis Trial

    March 4, 2026

    Patient Protect launches to tackle discrimination against UK medical cannabis patients

    March 4, 2026

    Get Lit, Get Fit: Runners High Chicago Is Building a 4/20 Tradition With Purpose

    March 3, 2026

    Virginia Lawmakers Advance Marijuana Resentencing Bills As Push To Legalize Commercial Sales Also Nears Finish Line

    March 3, 2026

    Why Jetty Extracts Didn’t Rush Expansion

    March 2, 2026
  • Lifestyle

    Weir All on Weed: What Bob Weir Really Thought About Pot

    March 4, 2026

    Ethan Hawke’s First Acting Award Was a Bong From High Times. He Has Not Forgotten It.

    March 2, 2026

    ‘The West Wing’ Freaked Out About Weed. ‘Veep’ Barely Blinked. The Evolution of Weed on Political TV

    February 28, 2026

    Tamara Anderson Is Not Here to Ask Permission

    February 26, 2026

    I Was Wrong About the Hippies

    February 24, 2026
  • Law

    IRC 280E Still Applies to Your Marijuana Business, Unfortunately

    February 25, 2026

    Client Challenge

    February 17, 2026

    Brazil legalizes medical cannabis cultivation, expands patient access

    February 2, 2026

    Florida steps up ‘criminal probe’ of marijuana legalization campaign

    February 1, 2026

    Schedule 3 means new cybersecurity rules for cannabis operators

    January 30, 2026
  • Business

    Why Accessories Matter to Cannabis Companies Playing the Long Game – Cannabis & Tech Today

    March 4, 2026

    New York Summit Returns November 6 – Cannabis & Tech Today

    March 3, 2026

    Monsanto Never Cracked Weed. 2026 Might Open the Door

    March 1, 2026

    Marijuana Kiosks For Seniors Are Coming To Independent Living Communities Across Arizona

    February 28, 2026

    Accelerant Manufacturing Aligns Innovation with American-Made Production – Cannabis & Tech Today

    February 26, 2026
  • Education

    Hemp THC Drinks Are Exploding. Here’s Why the Alcohol Lobby Is Panicking.

    March 4, 2026

    CBD and the Aging Population—What Science Says Today – Cannabis & Tech Today

    March 2, 2026

    Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most

    February 28, 2026

    Top 10 Strains for Beginners to Grow

    February 26, 2026

    Science, Benefits & How to Choose Quality

    February 24, 2026
  • Vaping

    Review: Lodestone LC Lite – Innokin

    March 4, 2026

    Unveiling the Surprising Health Benefits of Nicotine

    March 4, 2026

    The Ultimate Guide to Every Taste and Feature – Guide To Vaping

    March 2, 2026

    A Beginner’s Guide to DIY Vaping

    March 2, 2026

    The Latest on the War on Nicotine: From New York to Seoul More Policymakers Choose Senseless Restrictions

    February 28, 2026
Smoke Insights
You are at:Home»News»Congress Should Delay The Federal Hemp Ban And Instead Enact Regulations For THC And CBD Products (Op-Ed)
News

Congress Should Delay The Federal Hemp Ban And Instead Enact Regulations For THC And CBD Products (Op-Ed)

adminBy adminFebruary 16, 2026No Comments5 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

“Republicans, Democrats and independents alike understand that regulation is better than prohibition, and that good science takes time.”

By Mike Simpson, Lovewell Farms via Rhode Island Current

At a moment when Americans across the political spectrum say they want evidence-based policy, Congress is on the verge of repeating a familiar mistake: banning first and studying later.

Bipartisan legislation recently introduced in both the U.S. House and Senate would delay the impending federal ban on hemp-derived products. This is not to legalize anything new, but instead to give regulators, researchers and farmers time to do what Congress says it wants to do: Gather data, set clear rules and regulate responsibly.

I write this as a hemp farmer and small-business owner myself. Having started Lovewell Farms in 2018, I know firsthand the implications a ban on hemp-derived products would have on my farm, Rhode Island’s only USDA-certified organic hemp farm. Here is what legislators may not fully understand: Hemp is not something that can be turned on and off with a vote. Farmers need to know in the next 100 days if the plant they will harvest in October will be legal in November.

Seeds are planted in April. Fields are cultivated all summer. Crops are harvested in October. A federal ban that takes effect in November lands after farmers have already committed an entire season’s labor, capital and compliance costs. There is no rewind button for agriculture. That uncertainty is already forcing farms to shut down. A sudden ban would finish the job.

The Senate bill (S.3686), introduced by Sens. Amy Klobuchar, a Minnesota Democrat, and co-sponsors Rand Paul, a Kentucky Republican, and Jeff Merkley, an Oregon Democrat, would delay enforcement of the hemp-derived product ban for two years, allowing Congress to pursue regulatory alternatives rather than defaulting to prohibition. A companion bill in the House (H.7010), led by Rep. Jim Baird, an Indiana Republican, also with bipartisan cosponsors, would do the same.

Together, these bills recognize a basic agricultural reality: Farmers need predictability before they plant.

Importantly, Congress is not only proposing a delay, it is also debating regulation. The Hemp Enforcement, Modernization, and Protection (HEMP) Act is yet another bipartisan bill introduced in the House (H.7212) that would establish a federal framework for hemp-derived products, including clear safety standards, labeling requirements, enforcement authority and defined potency limits by product type. The proposal sets per-serving and per-package caps for non-intoxicating oral hemp products, inhalables, topicals and THC-containing items, demonstrating that consumer protection and responsible oversight are achievable without resorting to prohibition.

Taken together, these bills show that Congress has viable, bipartisan alternatives to an outright ban, if it chooses to use them.

At this point, this is not a debate about intoxicating THC limits. It is about whether hemp policy will be guided by science or by fear. That distinction matters, because federal science is finally catching up. In 2025, the Trump administration issued an executive order directing federal agencies to expand cannabis and cannabidiol (CBD) research, including the use of large federal health datasets such as Medicare records to study safety, efficacy and outcomes.

The order did not legalize CBD or add it as a Medicare benefit, but it explicitly acknowledged that cannabinoids require rigorous study before sweeping policy decisions are made. Congress is now hurtling toward prohibition at the exact moment the federal government is building the science-based research infrastructure needed to answer the hard questions.

Even the concerns raised by opponents of hemp-derived products argue for regulation, not bans. If products require clearer labeling, age restrictions, potency standards or enforcement tools, like those already in place in Rhode Island, those are state-by-state regulatory challenges. Rhode Island already regulates hemp products. Farmers and businesses here should not be penalized because other states have dragged their feet to create a regulated market.

Prohibition does not solve these issues; it simply pushes them out of sight, into unregulated markets that are less safe for consumers. A hemp ban would also push production overseas. If hemp farming in the United States collapses, demand will not disappear. It will just shift to imported cannabinoids from countries like Canada or China, where American regulators have far less visibility or control. That outcome harms local farmers, consumers, and public safety alike.

Rhode Island’s Reps. Gabe Amo and Seth Magaziner previously voted against a federal hemp ban embedded in a larger spending bill. That was the right call. Sens. Jack Reed and Sheldon Whitehouse, however, explicitly voted to keep the hemp ban language in that same bill. Rhode Island’s senators now have an opportunity to support local farmers and small businesses by cosponsoring this bipartisan delay bill (S.3686). Rhode Island’s representatives can do the same with the corresponding companion bill in the House (H.7010).

This is one of the few issues in Congress that remains genuinely bipartisan. Republicans, Democrats and independents alike understand that regulation is better than prohibition, and that good science takes time. Congress should not dismantle a domestic $30 billion agricultural industry with over 300,000 jobs just as meaningful research is beginning. A temporary delay protects farmers, supports small businesses, keeps hemp farming rooted here in the United States and allows policymakers to regulate with evidence rather than panic.

Prohibition without evidence is not policymaking. Rhode Island’s delegation should stand with farmers, small businesses and science by cosponsoring the bipartisan bills that delay this ban and allow regulation to catch up with reality.

Mike Simpson is the co-founder of Lovewell Farms, Rhode Island’s only U.S. Department of Agriculture (USDA) organic hemp farm. He is also a historian, educator and longtime advocate for policy reform. He was previously deputy director for Regulate Rhode Island and an initiative coordinator for Marijuana Policy Project in Maine. He now lives in Providence and farms in the village of Hope Valley in Hopkinton.

This story was first published by Rhode Island Current.

Photo courtesy of Max Jackson.

Source link

Ban CBD Congress Delay Enact Federal Hemp OpEd Products Regulations THC
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleEmotional Zombies: How Weed Can Teach Us to Feel (Again)
Next Article Target Begins Selling THC-Infused Cannabis Drinks As Congress Debates Possible Hemp Law Reversal
admin

Related Posts

Hemp THC Drinks Are Exploding. Here’s Why the Alcohol Lobby Is Panicking.

March 4, 2026

Ananda Pharma to Begin Dosing in NHS CBD Endometriosis Trial

March 4, 2026

Patient Protect launches to tackle discrimination against UK medical cannabis patients

March 4, 2026
Leave A Reply Cancel Reply

Our Picks

Review: Lodestone LC Lite – Innokin

March 4, 2026

Unveiling the Surprising Health Benefits of Nicotine

March 4, 2026

Why Accessories Matter to Cannabis Companies Playing the Long Game – Cannabis & Tech Today

March 4, 2026

Hemp THC Drinks Are Exploding. Here’s Why the Alcohol Lobby Is Panicking.

March 4, 2026
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Vaping

Review: Lodestone LC Lite – Innokin

By adminMarch 4, 20260

An Easy Electronic Hookah The Lodestone consists of two elements. One part, the LC Lite,…

Unveiling the Surprising Health Benefits of Nicotine

March 4, 2026

Why Accessories Matter to Cannabis Companies Playing the Long Game – Cannabis & Tech Today

March 4, 2026

Hemp THC Drinks Are Exploding. Here’s Why the Alcohol Lobby Is Panicking.

March 4, 2026

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Review: Lodestone LC Lite – Innokin

March 4, 2026

Unveiling the Surprising Health Benefits of Nicotine

March 4, 2026

Why Accessories Matter to Cannabis Companies Playing the Long Game – Cannabis & Tech Today

March 4, 2026
Sponsors
Copyright © 2026. SmokeInsights.com
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.